The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases (vol 80, pg 99, 2020)

首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases (vol 80, pg 99, 2020)

【24h】

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases (vol 80, pg 99, 2020)

机译：生物纤米的未来：免疫介导的炎症疾病的最大化益处（Vol 80，PG 99,2020）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The affiliation of the corresponding author Silvio Danese, which currently reads.

机译：当前读的相应作者Silvio Danese的隶属关系。

著录项

来源
《Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts》 |2020年第10期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases (vol 80, pg 99, 2020) [J] . Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2020,第10期

机译：生物纤米的未来：免疫介导的炎症疾病的最大化益处（Vol 80，PG 99,2020）
2. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：生物仿生的未来：在免疫介导的炎症疾病中最大化益处
3. Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents (vol 34, pg 27, 2020) [J] . BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2020,第2期

机译：用于风湿病，斑块牛皮癣和炎症性肠病的生物仿制性的免疫原性：临床试验和监管文件的综述（Vol 34，PG 27,2020）
4. ORAL CYCLOSPORINE USE IN DOGS IN INFLAMMATORY AND IMMUNE-MEDIATED DISEASES [C] . Todd M. Archer Conference of the American College of Veterinary Internal Medicine . 2014

机译：在炎症和免疫介导的疾病中的狗的口腔环孢菌素使用
5. The evaluation of an Employee Counseling Service: A cost/benefit assessment and program recommendations for future priority and benefit maximization. [D] . Santangelo, Linda Kay. 1996

机译：员工咨询服务的评估：成本/效益评估和计划建议，以实现未来的优先级和收益最大化。
6. Benefits Concerns and Future Directions of Biosimilars in Inflammatory Bowel Disease [O] . Brian Feagan 2017

机译：炎症性肠病中生物仿制药的益处关注和未来方向
7. Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases [O] . HoUng Kim, Rieke Alten, Luisa Avedano, 2020

机译：纠正：生物纤米的未来：在免疫介导的炎症疾病中最大化益处

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases (vol 80, pg 99, 2020)

摘要

著录项

相似文献

相关主题

期刊订阅